Long-term survival after surgical resection for huge hepatocellular carcinoma: Comparison with transarterial chemoembolization after propensity score matching

Journal of Gastroenterology and Hepatology (Australia)

Volumn 29, Issue 5, 2014, Pages 1043-1048

  Min, Yang Won ^a   Lee, Jun Hee ^a   Gwak, Geum Youn ^a   Paik, Yong Han ^a   Lee, Joon Hyoek ^a   Rhee, Poong Lyul ^a   Koh, Kwang Cheol ^a   Paik, Seung Woon ^a   Yoo, Byung Chul ^a   Choi, Moon Seok ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Huge hepatocellular carcinoma; Surgical resection; Transarterial chemoembolization

Indexed keywords

ALBUMIN; IODINATED POPPYSEED OIL;

ACUTE LUNG INJURY; ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; ASCITES; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CHEMOEMBOLIZATION; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUGE HEPATOCELLULAR CARCINOMA; HUMAN; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER RESECTION; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MASCULINITY; ONCOLOGICAL PARAMETERS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPENSITY SCORE; SOLITARY TUMOR; SURGICAL MORTALITY; SURVIVAL PREDICTION; TUMOR INVASION; UNILOBAR TUMOR EXTENT; CARCINOMA, HEPATOCELLULAR; COHORT ANALYSIS; LIVER NEOPLASMS; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; SURVIVAL RATE; TIME; TREATMENT OUTCOME;

ADULT; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPENSITY SCORE; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84898879674     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12504     Document Type: Article

References (19)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 2005; 55: 74-108.
2. Bruix J, Sherman M, Llovet JM etal. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J. Hepatol. 2001; 35: 421-430.
3. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011; 53: 1020-1022.
4. Jwo SC, Chiu JH, Chau GY, Loong CC, Lui WY. Risk factors linked to tumor recurrence of human hepatocellular carcinoma after hepatic resection. Hepatology 1992; 16: 1367-1371.
5. Adachi E, Maeda T, Kajiyama K etal. Factors correlated with portal venous invasion by hepatocellular carcinoma: univariate and multivariate analyses of 232 resected cases without preoperative treatments. Cancer 1996; 77: 2022-2031.
6. Hsu HC, Sheu JC, Lin YH etal. Prognostic histologic features of resected small hepatocellular carcinoma (HCC) in Taiwan. A comparison with resected large HCC. Cancer 1985; 56: 672-680.
7. Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet 2012; 379: 1245-1255.
8. Poon RT, Fan ST, Wong J. Selection criteria for hepatic resection in patients with large hepatocellular carcinoma larger than 10cm in diameter. J. Am. Coll. Surg. 2002; 194: 592-602.
9. Chen XP, Qiu FZ, Wu ZD, Zhang BX. Hepatectomy for huge hepatocellular carcinoma in 634 cases. World J. Gastroenterol. 2006; 12: 4652-4655.
10. Yamashita Y, Taketomi A, Shirabe K etal. Outcomes of hepatic resection for huge hepatocellular carcinoma (>/=10cm in diameter). J. Surg. Oncol. 2011; 104: 292-298.
11. Choi GH, Han DH, Kim DH etal. Outcome after curative resection for a huge (>or=10cm) hepatocellular carcinoma and prognostic significance of gross tumor classification. Am. J. Surg. 2009; 198: 693-701.
12. Nagasue N, Kohno H, Chang YC etal. Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years. Ann. Surg. 1993; 217: 375-384.
13. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 2003; 37: 429-442.
14. Huang YH, Wu JC, Chen SC etal. Survival benefit of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma larger than 10cm in diameter. Aliment. Pharmacol. Ther. 2006; 23: 129-135.
15. Mok KT, Wang BW, Lo GH etal. Multimodality management of hepatocellular carcinoma larger than 10cm. J. Am. Coll. Surg. 2003; 197: 730-738.
16. Park JW. [Practice guideline for diagnosis and treatment of hepatocellular carcinoma]. Korean J. Hepatol. 2004; 10: 88-98.
17. Korean Liver Cancer Study Group and National Cancer Center, Korea. [Practice guidelines for management of hepatocellular carcinoma 2009]. Korean J. Hepatol. 2009; 15: 391-423.
18. D'Agostino RB, Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat. Med. 1998; 17: 2265-2281.
19. Luo J, Peng ZW, Guo RP etal. Hepatic resection versus transarterial lipiodol chemoembolization as the initial treatment for large, multiple, and resectable hepatocellular carcinomas: a prospective nonrandomized analysis. Radiology 2011; 259: 286-295.